• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Agios Pharmaceuticals Inc

+ Add to Watchlist

AGIO:US

38.2100 USD 0.3000 0.78%

As of 17:20:00 ET on 07/25/2014.

Snapshot for Agios Pharmaceuticals Inc (AGIO)

Open: 38.2800 Day's Range: 38.0200 - 38.8400 Volume: 136,441
Previous Close: 38.5100 52wk Range: 15.7700 - 50.3700 1-Yr Rtn: +37.54%

Stock Chart for AGIO

No chart data available.
  • AGIO:US 38.2100
  • 1D
  • 1M
  • 1Y
38.5100
Interactive AGIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AGIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.0600
Est. EPS (USD) (12/2014) -1.4700
Est. PEG Ratio -
Market Cap (M USD) 1,297.45
Shares Outstanding (M) 33.96
30 Day Average Volume 422,107
Price/Book (mrq) 10.0237
Price/Sale (ttm) 15.6369
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AGIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AGIO

Agios Pharmaceuticals Inc. discovers and develops therapeutics in the field of cancer metabolism. The Company develops drugs focusing on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.

David P SchenkeinChief Executive OfficerJ Duncan HiggonsChief Operating Officer
Craig MuirCTO/CIOChris BowdenChief Medical Officer
More Company Profile & Key Executives for AGIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil